| Beitragstitel |
Bimekizumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Pooled analysis from up to 3 years of treatment in 5 phase 3/3b clinical trials |
| Autoren |
-
Bruce Strober
Yale University
-
James G. Krueger
The Rockerfeller University
-
Nina Magnolo
University Hospital Münster
-
Ronald Vender
Dermatrials Research Inc.
-
Wolf-Henning Boehncke
Service de Dermatologie Hôpital Universitaire de Genève
-
Chih-ho Hong
University of British Columbia
-
Nicola Tilt
UCB Pharma
-
Fabienne Staelens
UCB Pharma
-
Bengt Hoepken
UCB Pharma
-
Susanne Wiegratz
UCB Pharma
-
Nicolas Hurni
UCB Pharma
Vortragender
-
Carle Paul
Toulouse University and CHU
|
| Präsentationsform |
Poster |
| Themengebiete |
-
1.1 Inflammatory and immune-mediated dermatoses
|
